JP2016504381A5 - - Google Patents

Download PDF

Info

Publication number
JP2016504381A5
JP2016504381A5 JP2015551671A JP2015551671A JP2016504381A5 JP 2016504381 A5 JP2016504381 A5 JP 2016504381A5 JP 2015551671 A JP2015551671 A JP 2015551671A JP 2015551671 A JP2015551671 A JP 2015551671A JP 2016504381 A5 JP2016504381 A5 JP 2016504381A5
Authority
JP
Japan
Prior art keywords
barrier
forming composition
disease
streptococcus
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015551671A
Other languages
English (en)
Japanese (ja)
Other versions
JP6901824B2 (ja
JP2016504381A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/066863 external-priority patent/WO2014107221A1/en
Publication of JP2016504381A publication Critical patent/JP2016504381A/ja
Publication of JP2016504381A5 publication Critical patent/JP2016504381A5/ja
Application granted granted Critical
Publication of JP6901824B2 publication Critical patent/JP6901824B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015551671A 2013-01-04 2013-10-25 微生物により引き起こされる若しくは悪化する疾患の治療方法、又はその症状の緩和方法 Active JP6901824B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361749195P 2013-01-04 2013-01-04
US61/749,195 2013-01-04
US201361829608P 2013-05-31 2013-05-31
US61/829,608 2013-05-31
US201361859960P 2013-07-30 2013-07-30
US61/859,960 2013-07-30
PCT/US2013/066863 WO2014107221A1 (en) 2013-01-04 2013-10-25 Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof

Publications (3)

Publication Number Publication Date
JP2016504381A JP2016504381A (ja) 2016-02-12
JP2016504381A5 true JP2016504381A5 (https=) 2016-12-08
JP6901824B2 JP6901824B2 (ja) 2021-07-14

Family

ID=51062409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015551671A Active JP6901824B2 (ja) 2013-01-04 2013-10-25 微生物により引き起こされる若しくは悪化する疾患の治療方法、又はその症状の緩和方法

Country Status (3)

Country Link
EP (1) EP2941255A4 (https=)
JP (1) JP6901824B2 (https=)
WO (1) WO2014107221A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012145307A1 (en) 2011-04-19 2012-10-26 Brian Sokol Method of inhibiting harmful microorganisms and barrier-forming composition therefor
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
US10388407B2 (en) 2014-10-21 2019-08-20 uBiome, Inc. Method and system for characterizing a headache-related condition
WO2016065075A1 (en) 2014-10-21 2016-04-28 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics
EP3687375A4 (en) * 2016-11-21 2022-01-19 Psomagen, Inc. METHOD AND SYSTEM FOR CHARACTERIZING A HEADACHE RELATED CONDITION

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749869B1 (en) * 1997-09-26 2004-06-15 Ecolab Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection
CA2545117A1 (en) * 2003-11-07 2005-05-26 Viratox, L.L.C. Virucidal activities of a combination of cetylpyridinium chloride and citric acid
US20050191270A1 (en) * 2004-02-27 2005-09-01 Hydromer, Inc. Anti-infectious hydrogel compositions
US20060019987A1 (en) * 2004-07-23 2006-01-26 Fust Charles A Methods and compositions for inhibiting, destroying, and/or inactivating viruses
JP2008535918A (ja) * 2005-04-11 2008-09-04 ナノバイオ コーポレーション 感染性の症状を処置するための四級アンモニウムハライド
US9149429B2 (en) * 2007-11-21 2015-10-06 The Procter & Gamble Company Preparations, methods and kits useful for the treatment of cough
WO2012145307A1 (en) * 2011-04-19 2012-10-26 Brian Sokol Method of inhibiting harmful microorganisms and barrier-forming composition therefor

Similar Documents

Publication Publication Date Title
JP2016504381A5 (https=)
CN103189065B (zh) 用于治疗上呼吸道病症的制剂
AU2019100465B4 (en) Treatment and prevention of the common cold using povidone-iodine
JP2013253094A5 (https=)
JP2018519361A (ja) 口腔、咽喉及び気道の障害の治療のための配合物
JP2013520448A5 (https=)
JP6901824B2 (ja) 微生物により引き起こされる若しくは悪化する疾患の治療方法、又はその症状の緩和方法
KR102430892B1 (ko) 비강 울혈을 치료/예방하기 위한 카르복실산
US20140051731A1 (en) Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
US20130216574A1 (en) Kit providing multiple unmet therapeutic effects
Schellack et al. Overview and management of colds and flu
WO2016004395A1 (en) Sore-throat compositions and related methods
US20150306042A1 (en) Body surface treatment composition and method
US9744125B2 (en) Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses
ECSP11010941A (es) Composición farmacéutica para el uso en el tratamiento de infecciones de transmisión sexual
CN117083057A (zh) 用于预防感染的组合物
CA3175820A1 (en) Compositions and methods for treating upper respiratory infections
CN114040756A (zh) 疾病控制方法
US20230241126A1 (en) Compositions and methods for disruption of biofilms using fractionated honey
US20160317467A1 (en) Method of treating or preventing infection
CN107596166A (zh) 一种缓解感冒头痛的中药组合物
JP2016504383A (ja) 体表面処理組成物及び処理方法
Hosakote et al. Role Of High Mobility Group Box 1 Protein In Respiratory Syncytial Virus Pathogenesis
Carson Therapeutic Potential of Tea Tree Oil for Scabies
HK1249851B (en) Treatment and prevention of the common cold using povidone-iodine